This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Habib, N., Hershman, M., Haberland, F. et al. The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. Br J Cancer 53, 697–699 (1986). https://doi.org/10.1038/bjc.1986.116
Issue Date:
DOI: https://doi.org/10.1038/bjc.1986.116
This article is cited by
-
Clinical value of seram TAG-72 as a tumor marker for pancreatic carcinoma
International journal of pancreatology (1994)
-
Laboratory tests in the diagnosis of the chronic pancreatic diseases
International journal of pancreatology (1988)